• 1. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 2. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
• 3. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 4. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 5. An atom-economical protocol for direct conversion of Baylis–Hillman alcohols to β-chloro aldehydes in water?
  Raktani Bikshapathi,Sai Prathima Parvathaneni,Vaidya Jayathirtha Rao Green Chem., 2017,19, 4446-4450

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridopyrazines Pyridopyrazines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridopyrazines

Introduction to 6-Bromopyrido[2,3-b]pyrazine (CAS No. 1204298-53-2)

6-Bromopyrido[2,3-b]pyrazine (CAS No. 1204298-53-2) is a versatile heterocyclic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique brominated pyrido-pyrazine scaffold, offers a wide range of potential applications in drug discovery and development. The chemical structure of 6-Bromopyrido[2,3-b]pyrazine consists of a pyridine ring fused with a pyrazine ring, with a bromine atom substituting at the 6-position. This structural feature imparts unique electronic and steric properties that make it an attractive candidate for various biological studies.

In recent years, the interest in 6-Bromopyrido[2,3-b]pyrazine has been driven by its potential as a lead compound for the development of novel therapeutic agents. Research has shown that compounds derived from this scaffold exhibit a broad spectrum of biological activities, including anti-inflammatory, antiviral, and anticancer properties. For instance, studies have demonstrated that derivatives of 6-Bromopyrido[2,3-b]pyrazine can effectively inhibit the activity of key enzymes involved in inflammatory pathways, making them promising candidates for the treatment of inflammatory diseases.

The pharmacological profile of 6-Bromopyrido[2,3-b]pyrazine has also been explored in the context of antiviral therapy. Recent research has highlighted its potential to inhibit viral replication by targeting specific viral proteins or host factors essential for viral infection. This makes 6-Bromopyrido[2,3-b]pyrazine an attractive scaffold for the development of broad-spectrum antiviral agents capable of combating multiple viral infections.

In the realm of cancer research, 6-Bromopyrido[2,3-b]pyrazine has shown promising anticancer activity against various cancer cell lines. Studies have indicated that derivatives of this compound can induce apoptosis and cell cycle arrest in cancer cells, thereby inhibiting tumor growth and metastasis. The mechanism of action is believed to involve the modulation of key signaling pathways implicated in cancer progression, such as the PI3K/AKT and MAPK pathways.

The synthetic accessibility of 6-Bromopyrido[2,3-b]pyrazine is another factor contributing to its popularity in medicinal chemistry. The brominated pyrido-pyrazine core can be synthesized through a series of well-established chemical reactions, allowing for the facile preparation of diverse derivatives with tailored biological activities. This synthetic flexibility enables researchers to optimize the pharmacological properties of these compounds through structure-activity relationship (SAR) studies.

Beyond its direct therapeutic applications, 6-Bromopyrido[2,3-b]pyrazine has also found use as a valuable building block in combinatorial chemistry and high-throughput screening (HTS) campaigns. Its unique structural features make it an excellent starting point for the generation of large libraries of compounds that can be screened for various biological activities. This approach has led to the identification of several hit compounds with promising pharmacological profiles.

The safety and toxicity profiles of 6-Bromopyrido[2,3-b]pyrazine and its derivatives are crucial considerations in their development as therapeutic agents. Preclinical studies have generally shown favorable safety profiles for these compounds, with minimal toxicity observed at therapeutic concentrations. However, further investigations are necessary to fully understand their long-term safety and potential side effects.

In conclusion, 6-Bromopyrido[2,3-b]pyrazine (CAS No. 1204298-53-2) represents a promising scaffold with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and versatile biological activities make it an attractive candidate for the development of novel therapeutic agents targeting inflammatory diseases, viral infections, and cancer. Ongoing research continues to uncover new insights into the mechanisms underlying its pharmacological effects, further solidifying its importance in the field.

• 1432059-85-2(3,6-dibromopyrido[2,3-b]pyrazine)
• 1838674-98-8(3,8-Dibromopyrido[2,3-b]pyrazine)
• 1699749-05-7(2-Bromo-9H-pyrrolo[2,3-b:4,5-c’]dipyridine)
• 64942-90-1(BENZO[B]PYRIDO[2,3-H][1,6]NAPHTHYRIDINE, 3-BROMO-)
• 1312440-90-6(6-Bromo-1h-imidazo4,5-cpyridine)
• 28279-52-9(5-bromo-3H-imidazo[4,5-b]pyridine)
• 219762-28-4(5-Bromo-2-methyl-3H-imidazo4,5-bpyridine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)